Meanwhile, Western blot analysis revealed an increase in the expression levels of BAX and cleaved PARP1 in Zn2+-treated ESCC cells compared to the control group (Figure 1B). The gene discussed is PARP1; the disease is esophageal squamous cell carcinoma.